Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Petreena Campbell"'
Autor:
Nicole Mavingire, Petreena Campbell, Tiantian Liu, Jonathan Wooten, Salma Khan, Xin Chen, Jason Matthews, Charles Wang, Eileen Brantley
Publikováno v:
Precision clinical medicine. 5(2)
Metastatic breast cancer is incurable and often due to breast cancer stem cell (CSC)-mediated self-renewal. We previously determined that aryl hydrocarbon receptor (AhR) agonist aminoflavone (AF) inhibits the expression of CSC biomarker α6-integrin
Autor:
Siddhartha Paul, Curtis Hose, Eric Jones, Erik Harris, John Connelly, Petreena Campbell, Mariaestela Ortiz, Thomas S. Dexheimer, Thomas Silvers, Penny Sellers Brady, Julie Grams, Tiffany Nikirk Rohrer, Karen Martin, Patricia Ramsey, Lori Bowles, Annamaria Rapisarda, Ralph E. Parchment, Beverly A. Teicher, James H. Doroshow, Nathan P. Coussens
Publikováno v:
Cancer Research. 82:3079-3079
One of the major challenges in preclinical cancer therapeutic development is establishing physiologically relevant in vitro assays that correlate with the in vivo responses of patient tumors to anticancer agents. By incorporating tumor cell heterogen
Cancer stem cells: Culprits in endocrine resistance and racial disparities in breast cancer outcomes
Autor:
Andrea I. Loaiza-Pérez, Jonathan V. Wooten, Melissa Davis, Nicole Mavingire, Petreena Campbell, Eileen Brantley, Joyce Aja
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Cancer Lett
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Cancer Lett
Breast cancer stem cells (BCSCs) promote endocrine therapy (ET) resistance, also known as endocrine resistance in hormone receptor (HR) positive breast cancer. Endocrine resistance occurs via mechanisms that are not yet fully understood. In vitro, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afd8f57b4b3ea8ea7c91d9210abf7f51
https://www.sciencedirect.com/science/article/abs/pii/S0304383520306649
https://www.sciencedirect.com/science/article/abs/pii/S0304383520306649
Autor:
Lancelot McLean, Sonya Whang, Juli Unternaehrer, Leah K. Rowland, Gabriell Thorne, Nicole Mavingire, Petreena Campbell, Dain Zylstra, Jonathan V. Wooten, Devin Daly, Eileen Brantley, Kristopher E. Boyle
Publikováno v:
Journal of Cellular Biochemistry. 120:6004-6014
Nearly 40,000 women die annually from breast cancer in the US. Clinically available targeted breast cancer therapy is largely ineffective in triple negative breast cancer (TNBC), characterized by tumors that lack expression of the estrogen receptor (
Autor:
Fiorella Cavalli, Melissa Davis, Olayemi O. Adeoye, Salma Khan, Jonathan V. Wooten, Rachel Schiff, Leah K. Rowland, Anna Opoku‐Agyeman, Eileen Brantley, Brittany D. Jenkins, Andrea I. Loaiza-Pérez, Gayathri Nagaraj, Petreena Campbell, Nicole Mavingire, Ubaldo Soto, Ashley Guevara, Laura Denham
Publikováno v:
Journal of Cellular Physiology. 234:108-121
More than 40% of patients with luminal breast cancer treated with endocrine therapy agent tamoxifen demonstrate resistance. Emerging evidence suggests tumor initiating cells (TICs) and aberrant activation of Src and Akt signaling drive tamoxifen resi
Autor:
Mariam M. Konaté, Smitha Antony, Yongzhong Wu, Annamaria Rapisarda, Petreena Campbell, David J. Mallick, Krishnendu Roy, James H. Doroshow, Becky A. Diebold, Guojian Jiang, Jennifer L. Meitzler, Jiamo Lu, Agnes Juhasz
Publikováno v:
Cancer Research. 81:2915-2915
Inflammatory bowel diseases are states of long-term inflammation of the colon resulting from an interplay of environmental factors and dysregulated immune responses. As inflammatory exposure increases over the time frame of active disease, patients w
Autor:
Eileen Brantley, Willie Davis, George Huang, Leah K. Rowland, Helen Jacobs, Simone Badal, David J. Gangemi, Greg Raner, Sheena Francis, Rupika Delgoda, Ashley Quitugua, Malyn May Asuncion Valenzuela, Pallavi Vendantam, Jonathan V. Wooten, Petreena Campbell, Louisa Amis, Dain Zylstra, Tzuen-Rong J. Tzeng
Publikováno v:
Journal of Applied Toxicology. 37:873-883
Quassinoids often exhibit antioxidant and antiproliferative activity. Emerging evidence suggests that these natural metabolites also display chemopreventive actions. In this study, we investigated the potential for the quassinoid glaucarubulone gluco
Autor:
Debbie Trail, Abigail Walke, Petreena Campbell, Marion Gibson, Carrie Bonomi, Kelly Dougherty, Luke H. Stockwin, Savanna Styers, Matthew R. Murphy, Yvonne A. Evrard, Annamaria Rapisarda, Jenna Moyer, Lara H. El Touny, James H. Doroshow, Tara Grinnage-Pulley, Erik Harris, Joseph P. Geraghty, John Mark Carter, Kevin Plater, Michael Mullendore, Tiffanie Chase, Nathan P. Coussens, Michelle M. Gottholm-Ahalt, John Connelly, Dianne L. Newton, Beverly A. Teicher, Ralph E. Parchment, Anna Wade, Mariah Baldwin, Curtis Hose, Kaitlyn Arthur, Melinda G. Hollingshead, Howard Stotler
Publikováno v:
Cancer Research. 80:3913-3913
Cancer organoids are heterogeneous 3D cellular clusters with complexities that mimic some characteristics of tumors in situ. Thus, assays performed with cancer organoids might enable better predictions of in vivo drug responses than those performed w
Autor:
Rupika Delgoda, Shaniece Wauchope, Jonathan V. Wooten, Maxine Gossell-Williams, Eileen Brantley, Petreena Campbell, JeAnn Watson, Nicole Mavingire
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 29:C126-C126
Triple-negative breast cancer (TNBC), characterized by tumors that lack expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), carries a poor prognosis. African American women develo
Autor:
Lancelot McLean, Cheri N. Watkins, Eileen Brantley, Louisa Amis, W. Joel Livingston, Lia C. Scott, Willie Davis, Petreena Campbell, Lawrence C. Sowers, Dain Zylstra, Agus Darwanto, Leah K. Rowland, Maheswari Senthil, Crystal E. Babb
Publikováno v:
Chemical research in toxicology, vol 28, iss 5
Breast tumors often show profound sensitivity to exogenous oxidative stress. Investigational agent 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203) induces aryl hydrocarbon receptor (AhR)-mediated DNA damage in certain breast cancer cells. S